27 May 2021 in Journal of Applied Clinical Medical Physics
Purpose: Electron radiation therapy dose distributions are affected by irregular body surface contours. This study investigates the feasibility of three‐dimensional (3D) cameras to substitute for the treatment planning computerized tomography (CT) scan by capturing the body surfaces to be treated for accurate electron beam dosimetry.Methods: Dosimetry was compared for six electron beam treatments to the nose, toe, eye, and scalp using full CT scan, CT scan with Hounsfield Unit (HU) overridden to water (mimic 3D camera cases), and flat‐phantom techniques. Radiation dose was prescribed to a depth on the central axis per physician’s order, and the monitor units (MUs) were calculated. The 3D camera spatial accuracy was evaluated by comparing the 3D surface of a head phantom captured by a 3D camera and that generated with the CT scan in the treatment planning system. A clinical case is presented, and MUs were calculated using the 3D camera body contour with HU overridden to water.Results: Across six cases the average change in MUs between the full CT and the 3Dwater (CT scan with HU overridden to water) calculations was 1.3% with a standard deviation of 1.0%. The corresponding hotspots had a mean difference of 0.4% and a standard deviation of 1.9%. The 3D camera captured surface of a head phantom was found to have a 0.59 mm standard deviation from the surface derived from the CT scan. In‐vivo dose measurements (213 ± 8 cGy) agreed with the 3D‐camera planned dose of 209 ± 6 cGy, compared to 192 ± 6 cGy for the flat‐phantom calculation (same MUs).Conclusions: Electron beam dosimetry is affected by irregular body surfaces. 3D cameras can capture irregular body contours which allow accurate dosimetry of electron beam treatment as an alternative to costly CT scans with no extra exposure to radiation. Tools and workflow for clinical implementation are provided.
11 January 2024 in Journal of Applied Clinical Medical Physics
Purpose: A well‐known limitation of multi‐leaf collimators is that they cannot easily form island blocks. This can be important in mantle region therapy. Cerrobend photon blocks, currently used for supplementary shielding, are labor‐intensive and error‐prone. To address this, an innovative, non‐toxic, automatically manufactured photon block using 3D‐printing technology is proposed, offering a patient‐specific and accurate alternative.Methods and materials: The study investigates the development of patient‐specific photon shielding blocks using 3D‐printing for three different patient cases. A 3D‐printed photon block shell filled with tungsten ball bearings (BBs) was designed to have similar dosimetric properties to Cerrobend standards. The generation of the blocks was automated using the Eclipse Scripting API and Python. Quality assurance was performed by comparing the expected and actual weight of the tungsten BBs used for shielding. Dosimetric and field geometry comparisons were conducted between 3D‐printed and Cerrobend blocks, utilizing ionization chambers, imaging, and field geometry analysis.Results: The quality assurance assessment revealed a −1.3% average difference in the mass of tungsten ball bearings for different patients. Relative dose output measurements for three patient‐specific blocks in the blocked region agreed within 2% of each other. Against the Treatment Planning System (TPS), both 3D‐printed and Cerrobend blocks agreed within 2%. For each patient, 6 MV image profiles taken through the 3D‐printed and Cerrobend blocks agreed within 1% outside high gradient regions. Jaccard distance analysis of the MV images against the TPS planned images, found Cerrobend blocks to have 15.7% dissimilarity to the TPS, while that of the 3D‐printed blocks was 6.7%.Conclusions: This study validates a novel, efficient 3D‐printing method for photon block creation in clinical settings. Despite potential limitations, the benefits include reduced manual labor, automated processes, and greater precision. It holds potential for widespread adoption in radiation therapy, furthering non‐toxic radiation shielding.
27 April 2024 in Radiotherapy and Oncology